Bamba S - Search Results

1

Assessment of Body Composition From CT Images at the Level of the Third Lumbar Vertebra in Inflammatory Bowel Disease.

Bamba S, Inatomi O, Takahashi K, Morita Y, Imai T, Ohno M, Kurihara M, Takebayashi K, Kojima M, Iida H, Tani M, Sasaki M. Bamba S, et al. Inflamm Bowel Dis. 2021 Aug 19;27(9):1435-1442. doi: 10.1093/ibd/izaa306. Inflamm Bowel Dis. 2021. PMID: 33236765

2

Increased expression of interleukin 17 in inflammatory bowel disease.

Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Bamba T, Fujiyama Y. Fujino S, et al. Among authors: bamba s, bamba t. Gut. 2003 Jan;52(1):65-70. doi: 10.1136/gut.52.1.65. Gut. 2003. PMID: 12477762 Free PMC article.

3

Role of fibroblast growth factor-2 in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human intestinal myofibroblasts.

Yasui H, Andoh A, Bamba S, Inatomi O, Ishida H, Fujiyama Y. Yasui H, et al. Among authors: bamba s. Digestion. 2004;69(1):34-44. doi: 10.1159/000076545. Epub 2004 Jan 30. Digestion. 2004. PMID: 14755151

4

Fibroblast growth factor-2 stimulates interleukin-6 secretion in human pancreatic periacinar myofibroblasts.

Andoh A, Bamba S, Fujino S, Inatomi O, Zhang Z, Kim S, Takayanagi A, Shimizu N, Fujiyama Y. Andoh A, et al. Among authors: bamba s. Pancreas. 2004 Nov;29(4):278-83. doi: 10.1097/00006676-200411000-00006. Pancreas. 2004. PMID: 15502643

5

Interleukin-17 and lipopolysaccharides synergistically induce cyclooxygenase-2 expression in human intestinal myofibroblasts.

Zhang Z, Andoh A, Inatomi O, Bamba S, Takayanagi A, Shimizu N, Fujiyama Y. Zhang Z, et al. Among authors: bamba s. J Gastroenterol Hepatol. 2005 Apr;20(4):619-27. doi: 10.1111/j.1440-1746.2004.03748.x. J Gastroenterol Hepatol. 2005. PMID: 15836713

6

Increased aggregation response of platelets in patients with inflammatory bowel disease.

Andoh A, Yoshida T, Yagi Y, Bamba S, Hata K, Tsujikawa T, Kitoh K, Sasaki M, Fujiyama Y. Andoh A, et al. Among authors: bamba s. J Gastroenterol. 2006 Jan;41(1):47-54. doi: 10.1007/s00535-005-1721-x. J Gastroenterol. 2006. PMID: 16501857

7

Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease.

Andoh A, Deguchi Y, Inatomi O, Yagi Y, Bamba S, Tsujikawa T, Fujiyama Y. Andoh A, et al. Among authors: bamba s. Oncol Rep. 2006 Jul;16(1):103-7. Oncol Rep. 2006. PMID: 16786130

8

Regulation of amphiregulin and epiregulin expression in human colonic subepithelial myofibroblasts.

Inatomi O, Andoh A, Yagi Y, Bamba S, Tsujikawa T, Fujiyama Y. Inatomi O, et al. Among authors: bamba s. Int J Mol Med. 2006 Sep;18(3):497-503. Int J Mol Med. 2006. PMID: 16865236

9

Modulation of platelet aggregation responses by leukocytapheresis therapy in patients with active ulcerative colitis.

Yagi Y, Andoh A, Inatomi O, Bamba S, Tsujikawa T, Fujiyama Y, Mitsuyama K, Yoshida T. Yagi Y, et al. Among authors: bamba s. J Gastroenterol. 2006 Jun;41(6):540-6. doi: 10.1007/s00535-006-1797-y. J Gastroenterol. 2006. PMID: 16868801

10

The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.

Deguchi Y, Andoh A, Yagi Y, Bamba S, Inatomi O, Tsujikawa T, Fujiyama Y. Deguchi Y, et al. Among authors: bamba s. Oncol Rep. 2006 Oct;16(4):699-703. Oncol Rep. 2006. PMID: 16969482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters